SicuteriFTestiAAnselmiB. Biochemical investigations in headache: increase in the hydroxyindoleacetic acid excretion during migraine attacks. Int Arch Allergy Appl Immunol1961;19:55–8.
2.
AnthonyMHinterbergerHLanceJW. The possible relationship of serotonin to the migraine syndrome. In: FreidmanAP ed Research and clinical studies in headache, vol 2. Basel: Karger1969:29–59.
3.
RydzewskiWWachowiczB. In: GreenR ed Current concepts in migraine research. New York: Raven Press, 1978.
4.
MalmgrenROlssonPTornlingGUngeG. The 5-hydroxytryptamine take-up mechanism in normal platelets and platelets from migraine and asthmatic patients. Thromb Res1980;18:733–41.
5.
PradalierALaunayJM. 5-hydroxytryptamine uptake by platelets from migrainous patients. Lancet1982;1:862.
GloverVSandierMGrantERoseFCOrtonDWilkinsonM. Transitory decrease in platelet monoamine-oxidase activity during migraine attacks. Lancet1977;1:391–3.
8.
BussoneGGiovanniniPBioardiABoeriR. A study of the activity of platelet monoamine oxidase in patients with migraine headaches or with “cluster headaches”. Eur Neurol1977;15:157–62.
GloverVLittlewoodJSandierMPeatfieldRSummersKCraigIRoseFC. Why is platelet monoamine oxidase activity low in some headache patients? In: RoseCF ed Advances in migraine research and therapy. New York: Raven Press, 1982.
11.
PeatfieldRCGawelMJGuthrieDLPearsonTCGloverVLittlewoodJSandierMRoseFC. Platelet size: no correlation with migraine or monoamine oxidase activity. J Neurol Neurosurg Psychiatry1982;45:826–9.
12.
AhterLBoullinDGPaasonenMK. Transport of taurine by normal human blood platelets. Br J Pharmacol1974;52:245–51.
13.
DhopeshVPBaskinSI. Change in platelet taurine and migraine. Headache1982;22:165–6.
14.
LittlewoodJGloverVSandierMPettyRPeatfieldRRoseFC. Platelet phenosulphotransferase deficiency in dietary migraine. Lancet1982; 1:983–6.
15.
BottomleyJMHaningtonEJonesRJChapmanD. Platelet lipid composition in human migraine. Headache1982;22:256–60.
16.
OxmanThEHitzemannRJSmithR. Platelet membrane lipid composition and the frequency of migraine. Headache1982;22:261–7.
17.
CouchJRHassaneinRS. Platelet aggregrability in migraine and relation of aggregability to clinical aspects of migraine. Neurol1976;16:348.
18.
DesmukhSVMeyerJSMoucheRJ. Platelet dysfunction in migraine: effect of self-medication with aspirin. Thrombos Haemosts (Stuttg.)1976;36:319–24.
19.
CouchJRHassaneinRS. Platelet aggregability in migraine. Neurol1977;27:843–8.
20.
JonesRJForsytheAMAmessJAL. In: CritchleyM eds Platelet aggregation in migraine patients during the headache-free interval. New York: Raven Press, 1982;33:275–89.
21.
GawelMBurkittMRoseFC. The platelet release reaction on subsequent platelet function. J Lab Clin Med1979;83:877–86.
22.
D'AndreaGToldoMCananziAFerro-MiloneF. Study of platelet activation in migraine: control by low doses of aspirin. Stroke1984;15:271–75.
23.
GawelMJGloverVPeatfieldRSandierMRoseFC. Platelet monoamine oxidase activity varies with platelet count during severe exercise and noradrenaline infusion. In: RoseFC ed Progress in migraine research 1. London: Pitman, 1981.
24.
NatteroGBullaALeviEPeyrettiF. Platelet aggregability and migraine: is their relationship a reality? In: RoseFC ed Progress in migraine research 1. London: Pitman, 1981.
HaningtonE. Migraine: a blood disorder?Lancet1978, ii:501–3.
28.
JosephRSteinerTJRoseFC. Does the mode of action of beta-adrenergic blockers in the prophylaxis of migraine involve alteration of platelet function? In: RoseFC ed 5th International Migraine Symposium Proceedings. Basel: Karger (in publication).
